JW Pharmaceutical Corporation (001065.KS) KSC

28,500.00

-150(-0.52%)

Updated at January 14 03:30PM

Currency In KRW

Valuation

Market Cap559.8B
Enterprise Value641.1B
P/E Ratio10.38
PEG Ratio0.48
Price/Sales Ratio0.82
Price/Book Ratio1.84
Enterprise/Revenue0.86
Enterprise/EBITDA3.55

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.08
Operating Margin0.13

Management Effectiveness

Return On Assets0.1
Return On Equity0.19

Income Statement

Revenue719.38B
Revenue/Share31,654.73
Gross Profit323.5B
EBITDA110.17B
Net Income65.04B
Diluted EPS2,644.47

Balance Sheet

Total Cash82.51B
Total Cash/Share3,417.81
Total Debt68.66B
Total Debt/Equity0.19
Current Ratio1.51
Book Value Per Share14,667.38

Price History

52-Week Change-5.63
52-Week High30,900
52-Week Low26,550
Moving Average 50 Days28,434
Moving Average 200 Days28,480.25

Statistics

Average Volume268
Shares Outstanding17.24M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0.18
Last Split Factor51:50
Last Split DateDecember 27, 2023